RxDoctor Payments Data

Nathan Lashley, DPM

Foot & Ankle Surgery · Tulsa, OKNPI 1598995649

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,505 of the $6,323 with a category attached, or 71.2%. It is spread thinly across 39 manufacturers, the largest accounting for just 20.0%. Reporting peaked in 2019 at $2,707 and has fallen 82.1% since, to $486 in 2025.

$6,323in general payments, 2019–2025

Across 220 payments — averaging $28.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pylant Medical$1K
  • Paragon 28, Inc.$1K
  • Organogenesis Inc.$475
  • Amgen$430
  • Smith+Nephew$339
  • Paratek Pharmaceuticals, Inc.$304
  • plus $2K from 33 others

What the payments were for

  • Travel & lodging$1,01516%
  • Food & beverage$4,50571%
  • Education$80313%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,323 in reported general payments places this provider in the 60th percentile of 71 foot & ankle surgery providers in Oklahoma.

See all foot & ankle surgery providers in Oklahoma

Medicare billing

Part B allowed, 2024
$123,278
Medicare patients
428
Services billed
1,533

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole48$852
Celecoxib15$643
Gabapentin62$618
Ciclopirox12$455
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav53$446
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34$258
Cephalexin38$176
Clindamycin Hcl17$158
Allopurinol18$130
Doxycycline Hyclate18$123
Ibuprofen17$113
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$112
Prednisone38$57

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →